Number of the day - $400m
Stryker enters soft tissue robotics with $400M investment in CMR Surgical "Stryker said Monday it has partnered with soft tissue robotics firm CMR Surgical, investing about $400 million into the company and becoming the exclusive U.S. distributor of CMR’s system. Cambridge, England-based CMR received Food and Drug Administration clearance for its latest robotic system last year to perform gallbladder procedures in the U.S. As of early 2026, the company had performed more than 45,000 procedures globally, J.P. Morgan analyst Robbie Marcus wrote in a research note. Stryker had been expected to enter the soft tissue robotics market for years, Stifel analyst Rick Wise wrote in a research note. With competitors Johnson & Johnson and Medtronic receiving FDA nods for their own robots in the U.S., Wise added, “it feels like a now or never moment for Stryker to make the decision.” Source: CMR
